Investing Legend Hints the End May Be Near for These 3 Iconic Stocks

Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

BMRN
Biomarin Pharmaceutical Inc
NASDAQ
57.44
Open 57.68 Prev Close 57.54
High 58.35 Low 57.31
Volume 1,690,233 Volume (Avg) 2,332
52 Week High 94.85 52 Week Low 52.93
Market Cap 11B PE Ratio 17.01

Shares Stats

Shares Outstanding192,000,000
Shares Float189,310,000
Shares Short5,150,000
Insider Holdings78%
Institution Holdings98.68%

About Biomarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme delivered through subcutaneous injection to reduce blood Phe concentrations. It also develops BRINEURA, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; ALDURAZYME, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase; KUVAN, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria, an inherited metabolic disease; and ROCTAVIAN, an adeno associated virus vector for the treatment of severe hemophilia A. The company's products under development include BMN 333, a longer-acting CNP for the treatment of multiple growth disorders, such as achondroplasia and hypochondroplasia; BMN 349, an oral therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency; and BMN 351, an oligonucleotide for the treatment of duchenne muscular dystrophy. It serves specialty pharmacies, hospitals, non-U.S. government agencies, distributors, and pharmaceutical wholesalers. The company has license and collaboration agreements with Catalyst Pharmaceutical Partners, Inc., and Ares Trading S.A. The company was incorporated in 1996 and is based in San Rafael, California.

General

NameBiomarin Pharmaceutical Inc
TickerBMRN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees3,040

Highlights

Analyst Target98.20
Market Cap11,029,300,000
PE Ratio17.01
PEG Ratio0.91
EBITDA955,153,024

Financials

Curr Year EPS Estimate4.30
Next Quarter EPS Estimate0.96
Profit Margin21.62%
Operating Margin27.12
Return on Assets0.08
Return on Equity0.12
Revenue3B
Earnings Per Share3.39
Revenue Per Share16.04
Gross Profit2,506,098,944
Quarterly Revenue Growth0.16

Valuation

Trailing PE16.97
Forward PE15.63
Price/Sales (Trailing 12 Mt.)3.61
Price/Book (Most Recent Quarter)1.83

Earnings

Most Popular

Appeals court overturns order that stripped some protections from pregnant Texas state workers

NEW YORK (AP) — A federal appeals court has upheld a law strengthening the rights of pregnant workers, vacating a judge's earlier order that had stripped those protections from Texas state employees.

Major Investors Bet Big on This "Unlisted" Stock - Ad

When the former Zillow exec whose first venture sold for $120M starts a new company, people notice. No wonder the VCs behind Uber and eBay also backed Pacaso. Their platform sells fractions of premier properties, rewriting a $1.3T market. And it works, earning over $110M in gross profit to date.

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate heart devices recently linked to injuries and deaths.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

Align Technology Stock Tumbles Wednesday: What's Going On?

Align Technology shares are tumbling in Wednesday's after-hours session after the company reported worse-than-expected results for the second quarter and issued soft guidance.

Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad

Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.

Berkshire Hathaway Faces $3.8 Billion Loss Tied to Kraft Heinz Stake

Berkshire Hathaway has reported a $3.8 billion impairment on its stake in Kraft Heinz, marking a significant setback for the billionaire investor.

$9 Target on a $1.50 Biotech. Time to Look Closer - Ad

This biotech is targeting a billion-dollar heart market. Analyst upside targets are in triple digit percentage gains.

Jury orders Tesla to pay more than $200 million in Autopilot crash case

MIAMI (AP) — A Miami jury decided that Elon Musk’s car company Tesla was partly responsible for a deadly crash in Florida involving its Autopilot driver assist technology and must pay the victims more than $200 million in punitive damages.

Billionaire Investor Buys Google And This Gold Miner Stock

John Paulson's hedge fund discloses the purchase of 9,000 shares of Alphabet.

4 Analysts. 4 Buy Ratings: Huge Potential Revaluation Ahead For This Biotech - Ad

This biotech is targeting a billion-dollar heart market. Analyst upside targets are in triple digit percentage gains.

Air quality concerns linger in the wake of steel plant explosion in Pennsylvania

The Pennsylvania county where an explosion at south of Pittsburgh killed and injured more than 10 others announced Thursday that it is stepping up air quality monitoring in the area of the sprawling facility that has a troubled environmental record.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

Apple's New Siri Voice-Control Feature Could Revolutionize User Experience

In a move that could redefine the way users interact with their iPhones, Apple is reportedly developing an enhanced version of App Intents for Siri.

Weiss Gold Veteran Makes Shocking New Call - Ad

Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.

Elliott Management Bets Against S&P 500, Nasdaq 100, Nvidia Stock In Second Quarter

Elliott Management places new bets against the market in the second quarter, while taking a new long position in Hewlett Packard Enterprise.

A top Federal Reserve official says dour jobs data backs the case for 3 rate cuts

NEW YORK (AP) — A top official at the Federal Reserve said Saturday that this month's stunning, is strengthening her belief that interest rates should be lower.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

WhatsApp And Telegram Users In Russia Face New Restrictions On Voice Calls As Trump-Putin Alaska Meet Looms

Russia has partially blocked audio calls on WhatsApp and Telegram as part of a broader internet control strategy, coinciding with rising tensions ahead of President Trump's planned meeting with Vladimir Putin in Alaska.

In juvenile detention, these students say they're not learning — and it's keeping them incarcerated

GAINESVILLE, Fla. (AP) — To earn his freedom, 15-year-old Cayden Gillespie had to complete three school assignments a day. But school had gone for Cayden and other incarcerated young people in Florida. And sometimes, he didn't understand it.

RFK Jr's FINAL Warning For American Seniors - Ad

For years liberals have called RFK Jr a QUACK... an alarmist... and a conspiracy theorist. But now it appears he was right about a COVID lab leak... He was right about microplastics... And he was right about FDA corruption. Now, he's issued a terrifying new warning that Americans need to hear in 2025. Millions are in the crosshairs... And if you were born before Jan 1st, 1965, this affects you most of all.

Trump narrows Fed chair candidates to four, excluding Treasury Secretary Bessent

WASHINGTON (AP) — President Donald Trump said Tuesday that he's whittled down his list of potential Federal Reserve chair candidates to four as he considers a successor to — a choice that could reset the path of the U.S. economy.

Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad

Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

Stocks Slip, Bitcoin Plunges On Inflation Spike: What's Moving Markets Thursday?

Wall Street struggled to extend record highs on Thursday, as investors opted to lock in profits and adopt a more cautious stance after U.S. producer inflation posted its largest increase in three years.

Major Investors Bet Big on This "Unlisted" Stock - Ad

When the former Zillow exec whose first venture sold for $120M starts a new company, people notice. No wonder the VCs behind Uber and eBay also backed Pacaso. Their platform sells fractions of premier properties, rewriting a $1.3T market. And it works, earning over $110M in gross profit to date.

Asian shares mostly climb after a rally for Apple led Wall Street higher

MANILA, Philippines (AP) — Asian shares mostly advanced and financial markets appeared to show scant if any reaction to higher tariffs on exports to the United States that took effect early Thursday.

Palantir Turning LLMs Into Sharper Company Insights, Fueling ARK Invest's AI Edge, Says Brett Winton

Palantir Technologies Inc. reached new all-time highs this week as ARK Invest's Chief Futurist Brett Winton outlined how the company's platform transforms large language models into specialized business intelligence tools, positioning it as a critical infrastructure layer in the AI revolution.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

Trump's Moves Push Intel To Strongest Week In 25 Years

Intel stock heads for its best week since January 2000 driven by vocal support from President Donald Trump. 

First Solar (FSLR) Stock Surges On New Treasury Tax Credit Rules

Shares of First Solar are trading higher Monday afternoon. The stock is gaining following new guidance from the Treasury Department and IRS concerning tax credits.

Better Than Bitcoin? (Top Crypto for Less Than $1) - Ad

Over the past 15 years, Bitcoin has outperformed stocks, bonds, and every other asset you could've bought. 2025 is already shaping up to be another banner year, with Bitcoin recently hitting a new all-time high. But there's a better way to profit from this new crypto rally. Most people don't know about it... and yet it's returned over 1,000% in 4 months. This could be the #1 way to invest in crypto right now.

Economist Warns Of 'Horrendous' Crypto Crash — But Says Big Profits Can Still Be Made Before Valuation Hits This Level

Macroeconomist and technical analyst Henrik Zeberg issued a stern warning about the cryptocurrency market on Tuesday, describing it as the “Bubble of this era” and predicting a big crash.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service